CAH Cardinal Health, Inc. Common Stock
NYSE · Health Care · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 11, 2026CAH स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
CAH स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 23 अप्रैल 2001 | 3-for-2 | फॉरवर्ड |
| 2 नवमबर 1998 | 3-for-2 | फॉरवर्ड |
| 17 दिसमबर 1996 | 3-for-2 | फॉरवर्ड |
| 1 जुलाई 1994 | 5-for-4 | फॉरवर्ड |
| 1 अक्टूबर 1991 | 5-for-4 | फॉरवर्ड |
| 1 अक्टूबर 1990 | 5-for-4 | फॉरवर्ड |
| 2 अक्टूबर 1989 | 5-for-4 | फॉरवर्ड |
| 9 सितमबर 1988 | 11-for-10 | फॉरवर्ड |
| 9 सितमबर 1987 | 11-for-10 | फॉरवर्ड |
Cardinal Health, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
History
Founded in 1971 as Cardinal Foods by Robert D. Walter, the company was initially a food wholesaler. After acquiring the Bailey Drug Company in 1979, it began whole selling drugs. The company went public on the NASDAQ stock exchange in 1983.
In 1988, Walter sold Cardinal Health's food operations to Roundy's. From 1991 to 1996, the company's sales grew from $1.2 billion to $8.9 billion. The company changed its name to Cardinal Health in 1994, and became the third-largest pharmaceutical wholesaler in the United States.
2000–2019
R. Kerry Clark, a former executive and vice chairman at Procter & Gamble, was appointed president and CEO in April 2006, with Robert D. Walter retaining Chairmanship of the board. In September 2008, the company announced Clark and Walter would retire and George S. Barrett would become the chairman and CEO.
In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called CareFusion with David Schlotterbeck as CEO. Cardinal Health is now traded on the NYSE under symbol CAH.
In December 2013, it was announced that Cardinal Health would partner with CVS Caremark to form a generic drug sourcing operation in the United States. The venture was named Red Oak Sourcing and began operations in July 2014.
Between 2014 and 2016, Cardinal, alongside McKesson Corporation, and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in April 2016.
In January 2018, Michael Kaufmann assumed the role of CEO after serving as CFO of the company.
Opioid lawsuits
In 2019, Cardinal was one of several drug distributors named in lawsuits related to the opioid crisis in the US. In July 2021, Cardinal Health and other pharmaceutical companies agreed to participate in a $26 billion settlement. Cardinal will pay $6.4 billion over 18 years.
In May 2020, Oklahoma Attorney General Mike Hunter sued Cardinal Health in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against AmerisourceBergen and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."
2020–present
As of August 2021, it is ranked 14 on the Fortune 500 list with FY2020 annual revenue of $152.9 billion. The firm employs 57,000 people worldwide.
Acquisitions
In 1995, Medicine Shoppe International, the country's largest franchiser of retail pharmacies, was acquired. The merger represented the first non-distribution acquisition by Cardinal Health.
In 1996, Cardinal Health acquired Pyxis Corporation, a company that developed automated pill dispensers for hospitals, for $867 million.
In 1997, Cardinal Health planned to purchase Bergen Brunswig Corp., to which McKesson Corporation responded with a bid to purchase Amerisource. Instead, Amerisource and Bergen merged into AmerisourceBergen. Later that year, Cardinal Health completed the acquisition of Owen Healthcare, the second-largest provider of pharmacy management services in the U.S. at the time.
In 1999, the firm acquired the Chicago-based medical products manufacturer and distributor, Allegiance Healthcare (formerly a division of Baxter Healthcare). In 2001, the company acquired Bindley Western Industries, a wholesale distributor of pharmaceuticals based in Indianapolis.
In April 2006, Cardinal Health purchased Niagara Falls-based ParMed Pharmaceuticals for $40.1 million. In June 2007, the firm announced the completion of a tender offer for VIASYS Healthcare.
In June 2010, Cardinal Health announced plans to purchase Healthcare Solutions Holding, a specialty pharmaceutical services company, for $517 million. In December 2010, the company acquired Kinray, an independent pharmaceutical wholesaler, increasing Cardinal Health's presence in the independent pharmacy market by 40 percent. From 2010 to 2014, Cardinal Health acquired 18 companies including Yong Yu, a Chinese drug distributor. Cardinal sold Yong Yu in 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion.
On March 18, 2013, Cardinal Health acquired the Twinsburg, Ohio-based privately held medical supply distributor AssuraMed, and with it its subsidiaries including Edgepark Medical Supplies, for $2.7 billion. AssuraMed was backed by private equity firms Clayton, Dubilier & Rice and Goldman Sachs Alternatives.
In July 2014, Cardinal Health and CVS formed Red Oak Sourcing, the largest generic drug sourcing operation in the United States. The companies started buying generic drugs around the world to sell in U.S. markets.
In March 2015, Cardinal Health signed an agreement to acquire Johnson & Johnson's Cordis (medical) division, a cardiology and endovascular device manufacturer, for $1.94 billion. The acquisition was completed on October 4, 2015. Cardinal sold the division in August 2021 to Hellman & Friedman, a private equity firm, for $1 billion.
In April 2017, Cardinal Health announced the plan to acquire the patient product portfolio from Medtronic for $6.1 billion. The acquisition was completed on July 30, 2017.
In November 2024, Cardinal Health announced the plan to acquire Advanced Diabetes Supply Group (ADSG), a leading national direct-to-patient provider of diabetes medical supplies, for about $1.1 billion with plans to merge the company into its at-Home Solutions business. The at-Home Solutions business includes Edgepark Medical Supplies of Twinsburg, Ohio and United States Medical Supply (US MED) of Doral, Florida. The acquisition was complete by April 2024.
In August 2025, Cardinal Health announced that it would acquire a 75% stake in Solaris Health, the largest urology management services organization (MSO) in the United States, for $1.9 billion in cash.
In July 2026, Cardinal Health agreed to acquire AdaptHealth's diabetes health business and medical-supply provider Strive Medical in separate transactions worth approximately US$360 million in total. The acquisitions were intended to expand its at-Home Solutions business in diabetes and urological care.
Controversy
Role in the Opioid epidemic
Multiple legal settlements have demonstrated Cardinal Health's role in the US Opioid epidemic, though the company never admitted wrongdoing:
December 2016: Cardinal Health settled for $44 million for violations of the Controlled Substances Act brought in allegations from United States Attorneys in districts from Maryland, New York, Florida and Washington.
July 2021: Cardinal Health agreed to pay $6.4 billion to settle thousands of US lawsuits. They were one of four companies to pay $26 billion, including Johnson & Johnson, AmerisourceBergen and McKesson.
May 2022: Settled a derivative suit on behalf of shareholders for $124 million.
August 2024: Settlement with various health plans including insurers and third-party payers for $92.7 million.
August 2024: Settlement with the City of Baltimore for $152.5 million.
Restatements
In September 2004, Cardinal Health announced plans to restate past results for fiscal 2001, 2002, 2003, and the first three quarters of 2004 downward, after an accounting review and an ongoing federal investigation. In 2005, in connection with the Audit Committee's conclusions reached in September and October 2004, the company made certain reclassification and restatement adjustments to its fiscal 2004 and prior historical consolidated financial statements. According to The Wall Street Journal, "Analysts called the restatement decision troubling, yet limited in scope."
FDA action
In August 2006, Cardinal Health ceased production of its Alaris SE infusion pump after approximately 1300 units were seized by the United States Food and Drug Administration (FDA). In February 2007, Cardinal Health signed a consent decree with the FDA which promised procedures to guarantee the safety of the Alaris SE. After FDA inspections, Cardinal Health entered into a further consent agreement with the FDA in 2009.
DEA investigation into Oxycodone diversion
In 2008, Cardinal Health agreed to pay $34 million in civil penalties to settle DEA allegations that it failed to report suspicious orders of hydrocodone. The fine followed a 10-month DEA suspension of a Lakeland, Florida distribution facility and two others in New Jersey and Washington. On February 2, 2012, the Drug Enforcement Administration again suspended the license of the firm's Lakeland distribution center to distribute controlled substances on charges that it had allowed four Florida pharmacies to purchase excessive amounts of controlled substances, in particular oxycodone.
Cardinal Health obtained a restraining order against the suspension, but the suspension was upheld on February 29 by a Federal district court because the court agreed with the DEA that Cardinal Health's activities represented an "imminent danger to the public." The company stated that it blocked two of the pharmacies, (Brooks Pharmacy in Bonita Springs, Florida, and Gulf Coast Medical in Panama City, Florida), and notified the corporate owners of the two pharmacies that were part of national chains, two CVS stores in Sanford, Florida.
In February 2012, Joseph Rannazzisi, chief of the Drug Enforcement Administration’s Office of Diversion Control, issued immediate suspension orders against Cardinal's supply of oxycodone to suspected pill mills. These orders were filed after Deputy Attorney General James M. Cole met with Rannazzisi to ask if he had met with Cardinal about the investigation. Cole stated that he believed “it made good sense to listen to what Cardinal had to say” regarding the investigation. That year, Cardinal and the DEA reached a settlement that suspended Cardinal's facility in Lakeland, Florida from selling pain killers or other drugs for two years. In 2016, Cardinal was fined $44 million for after the investigation concluded.
In January 2022, Cardinal Health, Johnson & Johnson, McKesson, and AmerisourceBergen agreed to pay $26 billion to settle with all but five of the states suing them. Had the states gone to court, the companies could have faced up to $95 billion in penalties.
Finances
Annual financial statistics are displayed below:
Cardinal Health Foundation
The Cardinal Health Foundation is the charitable arm of Cardinal Health. The company makes annual product donations of over $9 million through international relief organizations and provides up to $1,000 in matching funds for every Cardinal Health employee that makes a charitable donation. In 2008, the foundation established its E3 Grant Program. Over the past seven years, the Foundation has invested more than $7.15 million in funding to 241 hospitals, health systems or other health-related organizations.
Cardinal Health also supports organizations such as Ronald McDonald House Charities, and was named Benefactor of the Year at the 2011 Corporate Caring Awards. In 2015, the foundation contributed $3 million to the Solutions for Patient Safety project, which has raised over $11 million nationally for efforts to improve safety initiatives in children's hospitals.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | CAH | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E | 32.95Y औसत ≈29.4 | ≈29.4 | 22.9 | अति मूल्यांकित | |
| PEG Ratio (PEG अनुपात) | ≈1.2 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | CAH | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| सकल मार्जिन (TTM) | 3.8%5Y औसत ≈3.5% | ≈3.5% | 4.3% | कमजोर | |
| परिचालन मार्जिन (TTM) | 1.0%5Y औसत ≈0.52% | ≈0.52% | 1.1% | अनुरूप | |
| EBITDA मार्जिन (TTM) | 1.4%5Y औसत ≈0.88% | ≈0.88% | 1.3% | अनुरूप | |
| प्रीटैक्स मार्जिन (TTM) | 0.86%5Y औसत ≈0.44% | ≈0.44% | 1.0% | औसत से नीचे | |
| शुद्ध लाभ मार्जिन (TTM) | 0.67%5Y औसत ≈0.27% | ≈0.27% | 0.63% | अनुरूप | |
| ROA | 3.1%5Y औसत ≈1.3% | ≈1.3% | 3.1% | अनुरूप | |
| ROE | -60.5%5Y औसत ≈-65.5% | ≈-65.5% | -4.6% | कमजोर | |
| ROIC | -71.1%5Y औसत ≈-13.6% | ≈-13.6% | 12.2% | कमजोर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | CAH | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| वर्तमान अनुपात (MRQ) | 0.95Y औसत ≈1.0 | ≈1.0 | 0.9 | कम तरलता | |
| Quick Ratio (त्वरित अनुपात) | 0.45Y औसत ≈0.5 | ≈0.5 | 0.5 | कम तरलता | |
| Interest Coverage (ब्याज कवरेज) | 7.55Y औसत ≈9.3 | ≈9.3 | 5.9 | मजबूत तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | CAH | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 14.2%5Y औसत ≈9.5% | ≈9.5% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 7.4%5Y औसत ≈9.1% | ≈9.1% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 9.4% | · | · | · | |
| EPS YoY | 12.1%5Y औसत ≈91.0% | ≈91.0% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 9.8%5Y औसत ≈83.7% | ≈83.7% | · | · | |
| EPS CAGR 3Y | 79.0% | · | · | · | |
| EPS CAGR 5Y | 28.3% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | 73.2% | · | · | · | |
| Net Income CAGR 5Y (शुद्ध आय CAGR 5Y) | 22.9% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | CAH | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 4.65Y औसत ≈4.6 | ≈4.6 | 4.5 | शीर्ष स्तर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 14.35Y औसत ≈13.2 | ≈13.2 | 15.7 | कमजोर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 18.85Y औसत ≈18.6 | ≈18.6 | 13.1 | शीर्ष स्तर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$4.3M | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
| एक्स-डेट | राशि | मुद्रा | यील्ड |
|---|---|---|---|
| अक्ट 1, 2026 | $0.52 | USD | ≈0.89% |
| जुल 1, 2026 | $0.52 | USD | ≈0.86% |
| अप्र 1, 2026 | $0.51 | USD | ≈0.96% |
| जन 2, 2026 | $0.51 | USD | ≈0.99% |
| अक्ट 1, 2025 | $0.51 | USD | ≈1.3% |
| जुल 1, 2025 | $0.51 | USD | ≈1.2% |
| अप्र 1, 2025 | $0.51 | USD | ≈1.5% |
| जन 2, 2025 | $0.51 | USD | ≈1.7% |
| अक्ट 1, 2024 | $0.51 | USD | ≈1.8% |
| जुल 1, 2024 | $0.51 | USD | ≈2.1% |
| मा 28, 2024 | $0.50 | USD | ≈1.8% |
| दिस् 29, 2023 | $0.50 | USD | ≈2.0% |
| अक्ट 2, 2023 | $0.50 | USD | ≈2.3% |
| जून 30, 2023 | $0.50 | USD | ≈2.1% |
| मा 31, 2023 | $0.50 | USD | ≈2.6% |
| दिस् 30, 2022 | $0.50 | USD | ≈2.6% |
| सित 30, 2022 | $0.50 | USD | ≈3.0% |
| जून 30, 2022 | $0.50 | USD | ≈3.8% |
| मा 31, 2022 | $0.49 | USD | ≈3.5% |
| दिस् 31, 2021 | $0.49 | USD | ≈3.8% |
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 31 दिसमबर 2026 | अग 11, 2026 | $2.91 | $2.44 | 19.1% |
| 30 जून 2026 | $2.60 | $2.44 | 6.4% | |
| 31 मार्च 2026 | $3.17 | $2.82 | 12.6% | |
| 31 दिसमबर 2025 | $2.63 | $2.40 | 9.4% | |
| 30 सितमबर 2025 | $2.55 | $2.20 | 15.9% | |
| 30 जून 2025 | $2.08 | $2.06 | 1.1% | |
| 31 मार्च 2025 | $2.35 | $2.19 | 7.4% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Cost of Revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B | $129.63B | $123.43B | $115.00B | $96.82B | |
| Gross Profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B | $6.54B | $5.71B | |
| SG&A Expense | $6.13B | $5.38B | $5.00B | $4.80B | $4.51B | $4.53B | $4.57B | $4.48B | $4.60B | $3.77B | $3.65B | $3.24B | |
| Operating Income | $2.61B | $2.27B | $1.24B | $752M | $-607M | $472M | $-4.10B | $2.06B | $126M | $2.12B | $2.46B | $2.16B | |
| Interest Expense | $348M | $215M | $51M | $84M | $147M | $180M | $238M | $294M | $329M | $201M | $178M | $141M | |
| Other Non-op | $31M | $41M | $9M | $-5M | $-22M | $47M | $1M | $-15M | $-23M | $5M | $-5M | $7M | |
| Pretax Income | $2.17B | $2.10B | $1.20B | $663M | $-784M | $323M | $-3.77B | $1.75B | $-228M | $1.92B | $2.28B | $1.97B | |
| Income Tax | $469M | $532M | $348M | $332M | $153M | $-289M | $-79M | $386M | $-487M | $630M | $845M | $755M | |
| Net Income | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| EPS (Basic) | $7.27 | $6.48 | $3.48 | $1.27 | $-3.37 | $2.09 | $-12.61 | $4.55 | $0.82 | $4.06 | $4.36 | $3.66 | |
| EPS (Diluted) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 | $4.32 | $3.62 | |
| Shares (Basic) | 236,000,000 | 241,000,000 | 245,000,000 | 261,000,000 | 279,000,000 | 292,000,000 | 293,000,000 | 300,000,000 | 313,000,000 | 317,000,000 | 327,000,000 | 332,000,000 | |
| Shares (Diluted) | 237,000,000 | 242,000,000 | 247,000,000 | 262,000,000 | 279,000,000 | 294,000,000 | 293,000,000 | 301,000,000 | 315,000,000 | 320,000,000 | 330,000,000 | 335,000,000 | |
| EBITDA | $3.57B | $3.06B | $1.95B | $1.42B | $96M | $1.25B | $-3.19B | $3.06B | $1.16B | $2.84B | $3.10B | $2.61B |
बैलेंस शीट
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B | $3.41B | $2.77B | $2.53B | $1.76B | $6.88B | $2.36B | $4.62B | |
| Short-term Investments | · | · | $200M | · | · | · | · | · | · | $65M | $113M | $91M | |
| Receivables | $13.81B | $13.24B | $12.08B | $11.11B | $10.56B | $9.10B | $8.26B | $8.45B | $7.80B | $8.05B | $7.41B | $6.52B | |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | $15.64B | $14.59B | $13.20B | $12.82B | $12.31B | $11.30B | $10.62B | $9.21B | |
| Other Current Assets | $2.76B | $2.41B | $2.66B | $2.29B | $2.02B | $2.84B | $1.71B | $1.95B | $1.93B | $2.12B | $1.58B | $1.40B | |
| Current Assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B | $31.05B | $25.94B | $25.75B | $24.55B | $28.34B | $21.96B | $21.75B | |
| PP&E (Net) | $3.03B | $2.86B | $2.53B | $2.46B | $2.36B | $2.36B | $2.37B | $2.36B | $2.49B | $1.88B | $1.80B | $1.51B | |
| PP&E (Gross) | $7.97B | $7.52B | $6.70B | $6.31B | $5.88B | $5.59B | $5.33B | $5.17B | $5.26B | $4.63B | $4.48B | $4.03B | |
| Accum. Depreciation | $4.93B | $4.66B | $4.17B | $3.85B | $3.52B | $3.23B | $2.96B | $2.81B | $2.77B | $2.75B | $2.68B | $2.53B | |
| Goodwill | $11.44B | $9.69B | $4.72B | $4.61B | $5.86B | $7.99B | $8.36B | $8.38B | $8.32B | $7.22B | $7.17B | $5.07B | |
| Intangibles | $2.19B | $2.49B | $1.73B | $1.47B | $1.77B | $2.10B | $2.92B | $3.43B | $3.91B | $1.99B | $1.99B | $948M | |
| Other Non-current Assets | $1.88B | $1.71B | $1.26B | $1.07B | $953M | $951M | $1.19B | $1.05B | $682M | $681M | $944M | $866M | |
| Total Assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B | |
| Accounts Payable | $38.28B | $34.71B | $31.76B | $29.93B | $27.13B | $23.70B | $21.37B | $21.54B | $19.68B | $17.91B | $17.31B | $14.37B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | $0 | |
| Current Liabilities | $43.90B | $38.90B | $35.64B | $33.74B | $30.55B | $27.62B | $23.61B | $24.11B | $22.89B | $21.22B | $19.70B | $17.24B | |
| Capital Leases | $861M | $654M | $400M | $375M | $388M | $374M | $341M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $1.75B | $1.81B | $1.95B | $1.70B | $328M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | · | |
| Common Stock | $2.89B | $2.96B | $2.92B | $2.75B | $2.81B | $2.81B | $2.79B | $2.76B | $2.73B | $2.70B | $3.01B | $3.00B | |
| Retained Earnings | $2.01B | $783M | $-286M | $-642M | $-280M | $1.21B | $1.17B | $5.43B | $4.64B | $4.97B | $6.42B | $5.52B | |
| Treasury Stock | $7.61B | $6.37B | $5.68B | $4.91B | $3.13B | $2.19B | $2.07B | $1.79B | $1.22B | $731M | $2.76B | $2.25B | |
| AOCI | $-165M | $-155M | $-167M | $-151M | $-114M | $-34M | $-104M | $-79M | $-92M | $-125M | $-116M | $-23M | |
| Stockholders' Equity | $-2.88B | $-2.78B | $-3.21B | $-2.96B | $-709M | $1.79B | $1.79B | $6.33B | $6.06B | $6.81B | $6.55B | $6.26B | |
| Liabilities + Equity | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B |
नकदी प्रवाह
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $956M | $790M | $710M | $692M | $692M | $783M | $913M | $1.00B | $1.03B | $717M | $641M | $451M | |
| Stock-based Comp | $367M | $244M | $121M | $96M | $81M | $89M | $90M | $82M | $85M | $96M | $111M | $110M | |
| Deferred Tax | $91M | $243M | $-104M | $-40M | $14M | $496M | $-961M | $-83M | $-1.01B | $291M | $87M | $219M | |
| Amort. of Intangibles | $361M | $303M | $264M | $281M | $311M | $428M | $512M | $531M | $574M | $395M | $355M | $191M | |
| Restructuring | $106M | $88M | $175M | $95M | $101M | $114M | $122M | $125M | $176M | $56M | $25M | $44M | |
| Other Non-cash | $2.05B | $-441M | $2.18B | $1.82B | $3.27B | $450M | $5.61B | $360M | $2.41B | · | $705M | $545M | |
| Operating Cash Flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B | $2.43B | $1.96B | $2.72B | $2.77B | $1.18B | $2.97B | $2.54B | |
| CapEx | $649M | $547M | $511M | $481M | $387M | $400M | $375M | $328M | $384M | $387M | $465M | $300M | |
| Investing Cash Flow | $-2.58B | $-5.59B | $-1.85B | $-454M | $567M | $-378M | $493M | $338M | $-5.61B | $-405M | $-4.08B | $-849M | |
| Debt Issued | $1.00B | $2.90B | $1.14B | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $347M | $2.46B | $357M | $-579M | $-885M | $-570M | $-1.40B | $-1.10B | $-954M | $-310M | $-6M | $-1.22B | |
| Stock Repurchased | $1.36B | $765M | $750M | $2.00B | $1.00B | $200M | $350M | $600M | $550M | $600M | $651M | $1.04B | |
| Net Stock Activity | $-1.36B | $-765M | $-750M | $-2.00B | $-1.00B | $-200M | $-350M | $-600M | $-550M | $-600M | $-651M | $-1.04B | |
| Dividends Paid | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M | |
| Financing Cash Flow | $-1.60B | $1.94B | $-847M | $-3.05B | $-2.46B | $-1.32B | $-2.20B | $-2.29B | $-2.28B | $3.75B | $-1.14B | $60M | |
| Net Change in Cash | $982M | $-1.26B | $1.06B | $-669M | $1.36B | $636M | $240M | $768M | $-5.12B | $4.52B | $-2.26B | $1.75B | |
| Taxes Paid | $338M | $444M | $191M | $156M | $-766M | $273M | $368M | $311M | $425M | $686M | $635M | $529M | |
| Free Cash Flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B | $2.03B | $1.58B | $2.39B | $2.38B | $797M | $2.51B | $2.24B | |
| Levered FCF | $4.25B | $1.69B | $3.21B | $2.32B | $2.55B | $1.69B | $1.35B | $2.16B | $2.76B | $662M | $2.39B | $2.15B |
लाभप्रदता
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% | 5.4% | 5.6% | |
| Operating Margin | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% | 0.29% | -2.7% | 1.4% | 0.09% | 1.6% | 2.0% | 2.1% | |
| Net Margin | 0.67% | 0.70% | 0.38% | 0.13% | -0.51% | 0.38% | -2.4% | 0.94% | 0.19% | · | 1.2% | 1.2% | |
| Pretax Margin | 0.86% | 0.94% | 0.53% | 0.31% | -0.42% | 0.20% | -2.5% | 1.2% | -0.17% | 1.5% | 1.9% | 1.9% | |
| EBITDA Margin | 1.4% | 1.4% | 0.86% | 0.69% | 0.05% | 0.77% | -2.1% | 2.1% | 0.85% | 2.2% | 2.5% | 2.5% | |
| ROA | 3.1% | 3.2% | 1.9% | 0.60% | -2.1% | 1.4% | -9.0% | 3.4% | 0.64% | · | 4.4% | 4.3% | |
| ROE | -60.5% | -52.1% | -27.6% | -14.7% | -172.5% | 34.1% | -91.1% | 22.0% | 4.0% | · | 22.3% | 19.2% | |
| ROIC | -71.1% | -61.1% | -27.5% | -10.5% | 101.9% | 49.9% | -224.3% | 25.4% | -2.4% | 18.6% | 23.6% | 21.3% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.3 | |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.1 | 0.0 | · | |
| Interest Coverage | 7.5 | 10.6 | 24.4 | 7.8 | -4.0 | 2.6 | -17.2 | 7.0 | 0.4 | 10.5 | 13.8 | 15.3 |
दक्षता
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.6 | 4.5 | 5.1 | 4.7 | 4.1 | 3.8 | 3.7 | 3.6 | 3.4 | 3.5 | 3.8 | 3.7 | |
| Inventory Turnover | 14.3 | 13.5 | 14.1 | 12.5 | 11.6 | 11.2 | 11.2 | 11.0 | 11.0 | 11.3 | 11.6 | 11.1 | |
| Receivables Turnover | 18.8 | 17.6 | 19.6 | 18.7 | 18.4 | 18.7 | 18.3 | 17.9 | 17.3 | 16.8 | 17.5 | 17.2 |
प्रति शेयर
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $1072.78 | $919.74 | $918.33 | $782.49 | $650.05 | $552.61 | $521.92 | $483.50 | $434.31 | $406.18 | $368.32 | $306.06 | |
| Cash Flow / Share | $21.83 | $9.90 | $15.23 | $10.84 | $11.19 | $8.26 | $6.69 | $9.04 | $8.79 | $3.70 | $9.00 | $7.58 | |
| Dividend Paid / Share | $2.04 | $2.02 | $2.00 | $1.98 | $1.96 | $1.94 | $1.92 | $1.91 | $1.85 | $1.80 | $1.55 | $1.37 | |
| EPS (TTM) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 | $4.32 | $3.62 |
विकास दरें
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 14.2% | -1.9% | 10.7% | 13.0% | 11.6% | 6.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.4% | 7.1% | 11.8% | 10.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.4% | 7.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 12.1% | 87.0% | 173.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 79.0% | · | 18.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 28.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 9.8% | 83.2% | 158.2% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 73.2% | · | 11.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 22.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -3.0% | -2.8% | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Net Income TTM | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| P/E | 32.9 | 26.0 | 28.5 | 75.1 | -15.5 | 27.4 | -4.1 | 10.4 | 60.3 | 19.3 | 18.1 | 23.1 | |
| Earnings Yield | 3.0% | 3.8% | 3.5% | 1.3% | -6.5% | 3.6% | -24.2% | 9.6% | 1.7% | 5.2% | 5.5% | 4.3% | |
| Payout Ratio | 28.6% | 31.6% | 58.6% | 201.1% | -59.9% | 93.8% | -15.4% | 42.3% | 226.9% | · | 35.9% | 37.9% | |
| Annual Payout | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M |
आय विवरण
| मेट्रिक | रुझान | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B | $59.87B | $54.87B | $57.44B | $54.65B | $53.42B | $50.50B | $51.47B | $49.59B | |
| Cost of Revenue | $61.11B | $58.44B | $63.23B | $61.69B | $57.96B | $52.76B | $53.32B | $50.38B | $57.98B | $52.93B | $55.59B | $52.91B | $51.61B | $48.69B | $49.78B | $48.00B | |
| Gross Profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B | $1.88B | $1.94B | $1.85B | $1.74B | $1.81B | $1.81B | $1.68B | $1.60B | |
| SG&A Expense | $1.62B | $1.54B | $1.50B | $1.46B | $1.48B | $1.31B | $1.31B | $1.28B | $1.28B | $1.27B | $1.27B | $1.19B | $1.23B | $1.17B | $1.18B | $1.20B | |
| Operating Income | $729M | $509M | $707M | $668M | $428M | $730M | $549M | $568M | $401M | $369M | $505M | $-32M | $162M | $604M | $-86M | $123M | |
| Interest Expense | · | · | $88M | $80M | $74M | $74M | $35M | $32M | $9M | $28M | $3M | $11M | $6M | $26M | $24M | $24M | |
| Other Non-op | $26M | $-16M | $11M | $10M | $30M | $9M | $-3M | $5M | $-1M | $1M | $10M | $-1M | $-10M | $-2M | $6M | $-3M | |
| Pretax Income | $554M | $392M | $630M | $598M | $384M | $665M | $511M | $541M | $391M | $342M | $512M | $-44M | $146M | $576M | $-104M | $96M | |
| Income Tax | $154M | $12M | $159M | $144M | $141M | $157M | $110M | $124M | $158M | $80M | $143M | $-33M | $143M | $209M | $-27M | $-3M | |
| Net Income | $398M | $399M | $467M | $450M | $239M | $506M | $400M | $416M | $235M | $261M | $368M | $-12M | $5M | $365M | $-77M | $98M | |
| EPS (Basic) | · | · | · | $1.89 | · | · | · | $1.71 | · | $1.07 | $1.50 | $-0.05 | · | $1.43 | $-0.30 | $0.36 | |
| EPS (Diluted) | · | · | · | $1.88 | · | · | · | $1.70 | · | $1.07 | $1.50 | $-0.05 | · | $1.41 | $-0.30 | $0.36 | |
| Shares (Basic) | · | 235,000,000 | 236,000,000 | 238,000,000 | · | 240,000,000 | 242,000,000 | 243,000,000 | · | 243,000,000 | 245,000,000 | 249,000,000 | · | 256,000,000 | 261,000,000 | 271,000,000 | |
| Shares (Diluted) | · | 236,000,000 | 237,000,000 | 239,000,000 | · | 241,000,000 | 243,000,000 | 245,000,000 | · | 245,000,000 | 246,000,000 | 249,000,000 | · | 258,000,000 | 261,000,000 | 273,000,000 | |
| EBITDA | · | $757M | $941M | $901M | · | $730M | $549M | $750M | · | $367M | $482M | $158M | · | $572M | $-119M | $308M |
बैलेंस शीट
| मेट्रिक | रुझान | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | $3.33B | $3.81B | $2.87B | $5.13B | $3.72B | $4.59B | $3.85B | · | $3.99B | $3.65B | $3.49B | |
| Receivables | $13.81B | $13.65B | $13.66B | $13.77B | $13.24B | $12.67B | $12.37B | $11.78B | $12.08B | $11.57B | $11.79B | $11.27B | · | $10.99B | $11.42B | $11.04B | |
| Inventory | $17.30B | $18.01B | $20.12B | $17.56B | $16.83B | $16.16B | $16.90B | $15.62B | $14.96B | $17.28B | $18.45B | $16.99B | · | $16.62B | $17.26B | $15.89B | |
| Other Current Assets | $2.76B | $2.47B | $2.67B | $2.60B | $2.41B | $2.40B | $2.62B | $2.59B | $2.66B | $3.16B | $2.82B | $2.58B | · | $1.90B | $2.26B | $2.27B | |
| Current Assets | $38.75B | $38.06B | $39.23B | $38.54B | $36.37B | $34.59B | $35.76B | $32.91B | $34.88B | $35.73B | $37.66B | $34.69B | · | $33.50B | $34.60B | $32.70B | |
| PP&E (Net) | $3.03B | $2.93B | $2.88B | $2.83B | $2.86B | $2.66B | $2.56B | $2.54B | $2.53B | $2.47B | $2.45B | $2.44B | · | $2.36B | $2.34B | $2.34B | |
| PP&E (Gross) | $7.97B | · | · | · | $7.52B | · | · | · | $6.70B | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.93B | · | · | · | $4.66B | · | · | · | $4.17B | · | · | · | · | · | · | · | |
| Goodwill | $11.44B | $11.41B | $11.61B | $9.71B | $9.69B | $8.91B | $5.49B | $4.72B | $4.72B | $4.79B | $4.02B | $4.03B | $4.61B | $5.00B | $4.99B | $5.67B | |
| Intangibles | $2.19B | $2.28B | $2.37B | $2.40B | $2.49B | $2.11B | $1.95B | $1.66B | $1.73B | $1.72B | $1.35B | $1.41B | · | $1.57B | $1.63B | $1.69B | |
| Other Non-current Assets | $1.88B | $2.00B | $2.00B | $1.75B | $1.71B | $1.60B | $1.25B | $1.23B | $1.26B | $1.17B | $1.10B | $1.15B | · | $951M | $927M | $985M | |
| Total Assets | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B | |
| Accounts Payable | $38.28B | $37.83B | $39.00B | $36.86B | $34.71B | $32.81B | $31.30B | $30.36B | $31.76B | $32.09B | $34.26B | $31.54B | · | $29.60B | $30.08B | $28.36B | |
| Current Liabilities | $43.90B | $41.99B | $43.31B | $40.27B | $38.90B | $36.66B | $35.22B | $34.68B | $35.64B | $36.31B | $38.29B | $35.06B | · | $32.50B | $33.21B | $31.56B | |
| Capital Leases | $861M | · | · | · | $654M | · | · | · | $400M | · | · | · | · | · | · | · | |
| Common Stock | $2.89B | $2.81B | $2.85B | $2.75B | $2.96B | $2.95B | $2.93B | $2.83B | $2.92B | $2.89B | $2.85B | $2.73B | · | $2.82B | $2.75B | $2.58B | |
| Retained Earnings | $2.01B | $1.73B | $1.46B | $1.12B | $783M | $664M | $283M | $14M | $-286M | $-289M | $-425M | $-654M | · | $-342M | $-560M | $-301M | |
| Treasury Stock | $7.61B | $7.22B | $7.03B | $6.58B | $6.37B | $6.38B | $6.03B | $5.96B | $5.68B | $5.70B | $5.72B | $5.40B | $4.91B | $4.55B | $4.25B | $3.88B | |
| AOCI | $-165M | $-161M | $-153M | $-159M | $-155M | $-176M | $-180M | $-155M | $-167M | $-160M | $-155M | $-165M | · | $-142M | $-146M | $-176M | |
| Stockholders' Equity | $-2.88B | $-2.83B | $-2.88B | $-2.88B | $-2.78B | $-2.95B | $-2.99B | $-3.28B | $-3.21B | $-3.27B | $-3.45B | $-3.49B | · | $-2.22B | $-2.21B | $-1.78B | |
| Liabilities + Equity | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B |
नकदी प्रवाह
| मेट्रिक | रुझान | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $241M | $248M | $234M | $233M | $209M | $207M | $192M | $182M | $186M | $177M | $175M | $172M | $176M | $175M | $170M | $171M | |
| Stock-based Comp | $58M | $129M | $87M | $93M | $153M | $31M | $30M | $30M | $33M | $31M | $28M | $29M | $27M | $21M | $25M | $23M | |
| Amort. of Intangibles | $95M | $95M | $84M | $87M | $89M | $77M | $69M | $68M | $73M | $64M | $63M | $64M | $70M | $69M | $71M | $71M | |
| Restructuring | $40M | $25M | $21M | $20M | $27M | $28M | $9M | $24M | $69M | $53M | $28M | $25M | $33M | $16M | $17M | $29M | |
| Other Non-cash | · | · | · | $197M | · | · | · | $-2.27B | · | · | · | $339M | · | · | · | $-281M | |
| Operating Cash Flow | $1.69B | $1.82B | $686M | $973M | $1.52B | $2.92B | $-396M | $-1.65B | $2.08B | $-54M | $1.16B | $528M | $863M | $1.36B | $597M | $23M | |
| CapEx | $264M | $146M | $131M | $108M | $232M | $126M | $99M | $90M | $193M | $112M | $114M | $92M | $217M | $109M | $85M | $70M | |
| Investing Cash Flow | $-281M | $-181M | $-1.98B | $-142M | $-1.63B | $-2.90B | $-976M | $-88M | $166M | $-1.85B | $-105M | $-63M | $-206M | $-91M | $-87M | $-70M | |
| Debt Issued | $0 | $0 | $0 | $1.00B | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | $488M | · | · | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | |
| Stock Repurchased | $350M | $250M | $383M | $375M | $0 | $375M | $15M | $375M | $0 | $0 | $250M | $500M | $500M | $250M | $250M | $1.00B | |
| Net Stock Activity | · | · | · | $-375M | · | · | · | $-375M | · | · | · | $-500M | · | · | · | $-1.00B | |
| Dividends Paid | $120M | $120M | $122M | $129M | $120M | $124M | $122M | $128M | $122M | $122M | $124M | $131M | $126M | $128M | $129M | $142M | |
| Financing Cash Flow | $-490M | $-483M | $-519M | $-110M | $663M | $-507M | $2.33B | $-540M | $-859M | $1.03B | $-353M | $-666M | $-592M | $-934M | $-362M | $-1.16B | |
| Net Change in Cash | $919M | $1.16B | $-1.82B | $719M | $548M | $-484M | $943M | $-2.27B | $1.39B | $-878M | $710M | $-206M | $58M | $336M | $162M | $-1.23B | |
| Free Cash Flow | · | · | · | $865M | · | · | · | $-1.74B | · | · | · | $453M | · | · | · | $-47M | |
| Levered FCF | · | · | · | $804M | · | · | · | $-1.76B | · | · | · | $456M | · | · | · | $-72M |
लाभप्रदता
| मेट्रिक | रुझान | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 4.1% | 3.6% | 3.6% | · | 3.9% | 3.5% | 3.6% | · | 3.5% | 3.2% | 3.2% | · | 3.5% | 3.2% | 3.2% | |
| Operating Margin | · | 0.84% | 1.1% | 1.0% | · | 1.3% | 0.99% | 1.1% | · | 0.67% | 0.84% | -0.03% | · | 1.1% | -0.23% | 0.28% | |
| Net Margin | · | 0.65% | 0.71% | 0.70% | · | 0.92% | 0.72% | 0.80% | · | 0.47% | 0.61% | 0.01% | · | 0.68% | -0.25% | 0.22% | |
| Pretax Margin | · | 0.64% | 0.96% | 0.93% | · | 1.2% | 0.92% | 1.0% | · | 0.62% | 0.85% | -0.05% | · | 1.1% | -0.27% | 0.22% | |
| EBITDA Margin | · | 1.2% | 1.4% | 1.4% | · | 1.3% | 0.99% | 1.4% | · | 0.67% | 0.84% | 0.29% | · | 1.1% | -0.23% | 0.62% | |
| ROA | · | 0.75% | 0.89% | 0.92% | · | 1.1% | 0.85% | 0.96% | · | 0.58% | 0.78% | 0.01% | · | 0.81% | -0.29% | 0.25% | |
| ROE | · | -13.8% | -15.9% | -14.6% | · | -16.3% | -12.4% | -12.3% | · | -9.4% | -12.5% | -0.19% | · | -23.6% | 21.4% | -56.7% | |
| ROIC | · | -17.4% | -18.3% | -17.6% | · | -18.9% | -14.4% | -13.4% | · | -8.5% | -10.1% | -0.09% | · | -16.4% | 5.1% | -7.8% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.9 | 0.9 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | · | 0.4 | 0.4 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | · | 8.0 | 8.3 | · | 9.9 | 15.7 | 17.8 | · | 11.1 | 60.2 | -1.0 | · | 20.4 | -4.8 | 5.5 |
दक्षता
| मेट्रिक | रुझान | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.3 | · | 1.1 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.1 | |
| Inventory Turnover | · | 3.4 | 3.4 | 3.7 | · | 3.2 | 3.0 | 3.1 | · | 3.1 | 3.1 | 3.2 | · | 3.0 | 3.1 | 3.1 | |
| Receivables Turnover | · | 4.6 | 5.0 | 5.0 | · | 4.5 | 4.6 | 4.5 | · | 4.9 | 5.0 | 4.9 | · | 4.8 | 4.9 | 4.9 |
प्रति शेयर
| मेट्रिक | रुझान | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | $258.22 | $276.91 | $267.82 | · | $227.71 | $227.42 | $213.38 | · | $224.13 | $233.52 | $219.05 | · | $195.69 | $197.20 | $181.70 | |
| Cash Flow / Share | · | · | · | $4.07 | · | · | · | $-6.72 | · | · | · | $2.18 | · | · | · | $0.08 | |
| Dividend / Share | · | $0.51 | $0.51 | $0.51 | · | $0.51 | $0.51 | $0.51 | · | $0.50 | $0.50 | $0.50 | · | $0.50 | $0.50 | $0.50 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $250.74B | $244.67B | $234.31B | · | $222.29B | $222.28B | $224.45B | · | $220.38B | $216.01B | $210.04B | · | $198.62B | $192.96B | $186.95B | |
| Net Income TTM | · | $1.55B | $1.66B | $1.59B | · | $1.56B | $1.31B | $1.28B | · | $622M | $726M | $281M | · | $519M | $-1.24B | $-1.11B | |
| Payout Ratio | · | · | · | 28.7% | · | · | · | 30.8% | · | · | · | 2620.0% | · | · | · | 129.1% | |
| Annual Payout | · | $491M | $495M | $495M | · | $496M | $494M | $496M | · | $503M | $509M | $514M | · | $533M | $541M | $552M |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| राजस्व | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B |
| सकल मार्जिन % | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% |
| परिचालन मार्जिन % | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% |
| शुद्ध आय | $1.71B | $1.56B | $852M | $330M | $-938M |
| तनुकरणित EPS | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 |
| मेट्रिक | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 |
| त्वरित अनुपात | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 |
| मेट्रिक | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B |
संस्थागत मालिक (13F) 1605 फाइलर्स · $54.4B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 156 (-26 पिछली तिमाही की तुलना में) | 81 (-19 पिछली तिमाही की तुलना में) | 530 (-24 पिछली तिमाही की तुलना में) | 574 (+58 पिछली तिमाही की तुलना में) | +7.4M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6461178523 | 31441258 | 11.88% | शेयर |
| BlackRock, Inc. | $6293114912 | 26490633 | 11.57% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $3632811706 | 15292186 | 6.68% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $3530205977 | 14860271 | 6.49% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3258822899 | 13717894 | 5.99% | शेयर |
| STATE STREET CORP | $2842909265 | 11967121 | 5.23% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $1531751894 | 6472810 | 2.82% | शेयर |
| Invesco Ltd. | $1126646236 | 4742576 | 2.07% | शेयर |
| MORGAN STANLEY | $1098793649 | 4625329 | 2.02% | शेयर |
| WCM INVESTMENT MANAGEMENT, LLC | $971445537 | 4112461 | 1.79% | शेयर |
| NORGES BANK | $885248810 | 3726422 | 1.63% | शेयर |
| BANK OF AMERICA CORP /DE/ | $689065528 | 2900596 | 1.27% | शेयर |
| NORTHERN TRUST CORP | $681536598 | 2868903 | 1.25% | शेयर |
| JPMORGAN CHASE & CO | $630412357 | 2668749 | 1.16% | शेयर |
| GOLDMAN SACHS GROUP INC | $566588458 | 2385033 | 1.04% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $499624076 | 2103149 | 0.92% | शेयर |
| FMR LLC | $490857853 | 2066248 | 0.90% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $490754373 | 2322438 | 0.90% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $469793667 | 1977579 | 0.86% | शेयर |
| Legal & General Group Plc | $438869762 | 1847406 | 0.81% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $411645774 | 1732808 | 0.76% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $369172278 | 1554017 | 0.68% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $315702986 | 1328940 | 0.58% | शेयर |
| AMERIPRISE FINANCIAL INC | $311391613 | 1310794 | 0.57% | शेयर |
| NORDEA INVESTMENT MANAGEMENT AB | $308748216 | 1297534 | 0.57% | शेयर |
| Bank of New York Mellon Corp | $308639982 | 1299209 | 0.57% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $281612012 | 1185468 | 0.52% | शेयर |
| Robeco Institutional Asset Management B.V. | $258918781 | 1089909 | 0.48% | शेयर |
| DEUTSCHE BANK AG\ | $238933097 | 1005780 | 0.44% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $230523823 | 970390 | 0.42% | शेयर |
| JANE STREET GROUP, LLC | $225610732 | 949700 | 0.41% | पुट ऑप्शन |
| Man Group plc | $222013123 | 934556 | 0.41% | शेयर |
| WELLS FARGO & COMPANY/MN | $219711690 | 924868 | 0.40% | शेयर |
| UBS Group AG | $218780954 | 920950 | 0.40% | शेयर |
| Amundi | $211809683 | 891605 | 0.39% | शेयर |
| Nuveen, LLC | $211731009 | 891274 | 0.39% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $203800043 | 857888 | 0.37% | शेयर |
| ProShare Advisors LLC | $197187154 | 830052 | 0.36% | शेयर |
| ROYAL BANK OF CANADA | $185518000 | 780931 | 0.34% | शेयर |
| BARCLAYS PLC | $177344480 | 746525 | 0.33% | शेयर |
| FEDERATED HERMES, INC. | $176399992 | 742549 | 0.32% | शेयर |
| SEI INVESTMENTS CO | $173413944 | 729965 | 0.32% | शेयर |
| JANE STREET GROUP, LLC | $169712864 | 714400 | 0.31% | कॉल ऑप्शन |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $163869121 | 693714 | 0.30% | शेयर |
| Allianz Asset Management GmbH | $163833492 | 689651 | 0.30% | शेयर |
| Swedbank AB | $159718953 | 672331 | 0.29% | शेयर |
| Swiss National Bank | $157644816 | 663600 | 0.29% | शेयर |
| JANUS HENDERSON GROUP PLC | $155390858 | 735467 | 0.29% | शेयर |
| Mitsubishi UFJ Asset Management Co., Ltd. | $141722832 | 596577 | 0.26% | शेयर |
| 1832 Asset Management L.P. | $139039117 | 585280 | 0.26% | शेयर |
कार्यकर्ता और 5%+ मालिक 3 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Cardinal Health, Inc. ×2 फाइलिंग | 5 जून 2014 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 2 जुलाई 2004 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 28 मई 2004 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 84 इनसाइडर्स · 45 अधिकारी · 37 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Jason M. Hollar | Chief Executive Officer | 19 अगस्त 2026 S | 190603 | 0 | 10 | $-29375516 |
| Deborah Weitzman | CEO, PSS Segment | 18 अगस्त 2026 S | 77901 | 0 | 3 | $-1731524 |
| Stephen M Mason | CEO, GMPD Segment | 18 अगस्त 2026 S | 18061 | 0 | 4 | $-8274118 |
| Michael C Kaufmann | CEO | 15 अगस्त 2022 M | 601065 | 0 | 0 | $0 |
| Victor L. Crawford | CEO, Pharmaceutical Segment | 15 अगस्त 2022 F | 105699 | 0 | 0 | $0 |
| Jon L Giacomin | CEO, Medical Segment | 15 अगस्त 2019 F | 61387 | 0 | 0 | $0 |
| Donald M Casey Jr. | CEO, Medical Segment | 15 सितमबर 2017 F | 146503 | 0 | 0 | $0 |
| Michael A Lynch | CEO, Medical Segment | 27 फ़रवरी 2012 M | 89204 | 0 | 0 | $0 |
| Kerry R Clark | Former Chairman and CEO | 1 सितमबर 2009 A | 238635 | 0 | 0 | $0 |
| Mark W Parrish | CEO - HSCS | 2 सितमबर 2007 F | 68041 | 0 | 0 | $0 |
| Ronald K Labrum | CEO-Supply Chain Svcs. | 16 मई 2006 M | 36082 | 0 | 0 | $0 |
| Joseph C Papa | Chmn & CEO, Pharm Techn & Svcs | 13 दिसमबर 2004 A | 14400 | 0 | 0 | $0 |
| Aaron E Alt | Chief Financial Officer | 18 अगस्त 2026 S | 20495 | 0 | 5 | $-10451104 |
| Jorge M Gomez | Chief Financial Officer | 8 नवमबर 2018 F | 39582 | 0 | 0 | $0 |
| Jeffrey William Henderson | Chief Financial Officer | 27 अगस्त 2014 M | 67190 | 0 | 0 | $0 |
| Richard J Miller | EVP & CFO | 17 नवमबर 2003 A | · | 0 | 0 | $0 |
| George L Fotiades | President & COO | 15 जनवरी 2003 P | 80278 | 0 | 0 | $0 |
| Mary C. Scherer | Chief Accounting Officer | 19 अगस्त 2026 S | 2811 | 0 | 2 | $-546473 |
| Michelle D. Greene | Chief Information Officer | 18 अगस्त 2026 S | 10330 | 0 | 6 | $-3373574 |
| Jessica L Mayer | Chief Legal/Compliance Officer | 18 अगस्त 2026 S | 33076 | 0 | 4 | $-6952485 |
| Valerie Christine Pitteroff | Chief Human Resources Officer | 15 अगस्त 2026 F | 11757 | 0 | 0 | $0 |
| Ola M Snow | Chief Human Resources Officer | 1 दिसमबर 2025 F | 15111 | 0 | 0 | $0 |
| Patricia M English | Chief Accounting Officer | 15 अगस्त 2022 F | 9000 | 0 | 0 | $0 |
| Brian S Rice | Chief Information Officer | 15 अगस्त 2022 F | 37850 | 0 | 0 | $0 |
| Michele Holcomb | EVP - Strategy & Corp. Dev. | 15 अगस्त 2022 F | 44491 | 0 | 0 | $0 |
| Stuart G Laws | SVP & Chief Accounting Officer | 15 अगस्त 2020 F | 12289 | 0 | 0 | $0 |
| Craig S Morford | Chief Legal/Compliance Officer | 3 दिसमबर 2018 F | 126301 | 0 | 0 | $0 |
| Patricia Morrison | Chief Information Officer | 31 अगस्त 2018 F | 30725 | 0 | 0 | $0 |
| Pamela O. Kimmet | Chief Human Resources Officer | 15 अगस्त 2018 F | 22612 | 0 | 0 | $0 |
| George S Barrett | Executive Chairman | 15 अगस्त 2018 F | 502630 | 0 | 0 | $0 |
| Carole S Watkins | Chief HR Officer | 20 मई 2016 M | 31585 | 0 | 0 | $0 |
| Falk T Stephen | EVP, Gen. Counsel & Corp. Sec. | 30 नवमबर 2015 G | 32455 | 0 | 0 | $0 |
| Meghan Fitzgerald | EVP, Strategy & Health Policy | 17 नवमबर 2015 F | 16760 | 0 | 0 | $0 |
| Mark R Blake | EVP - Strategy & Corp. Dev. | 7 नवमबर 2014 M | 20409 | 0 | 0 | $0 |
| Ivan K Fong | CLO & Secretary | 1 नवमबर 2008 F | 50886 | 0 | 0 | $0 |
| Vivek Jain | EVP - Corp. Dev. & Strategy | 26 सितमबर 2008 A | 39594 | 0 | 0 | $0 |
| Daniel J Walsh | EVP, Chf Ethcs & Compl Offcr | 26 नवमबर 2007 I | 1740 | 0 | 0 | $0 |
| Eric Slusser | EVP, CAO & Controller | 4 जून 2007 M | 8573 | 0 | 0 | $0 |
| Brendan A Ford | EVP-Corporate Development | 2 सितमबर 2006 F | 85978 | 0 | 0 | $0 |
| RUCCI ANTHONY J | EVP & Chief Admin. Officer | 6 सितमबर 2005 G | 55382 | 0 | 0 | $0 |
| Gary D Dolch | EVP - Quality & Reg. Affairs | 2 सितमबर 2005 A | 6137 | 0 | 0 | $0 |
| Jody R Davids | EVP & CIO | 2 सितमबर 2005 A | 4607 | 0 | 0 | $0 |
| Paul S Williams | EVP, CLO & Secretary | 17 फ़रवरी 2005 G | 7000 | 0 | 0 | $0 |
| Gary S Jensen | SVP - Corporate Controller | 23 अगस्त 2004 A | 2462 | 0 | 0 | $0 |
| Stephen S Thomas | EVP-Group Pres.-AIS | 24 फ़रवरी 2004 M | 31039 | 0 | 0 | $0 |
| Hall Patricia Hemingway | निदेशक | 15 अप्रैल 2026 A | 28645 | 0 | 1 | $-918880 |
| Michelle Brennan | निदेशक | 5 नवमबर 2025 A | 8086 | 0 | 0 | $0 |
| Robert Azelby | निदेशक | 5 नवमबर 2025 A | 4085 | 0 | 0 | $0 |
| Nancy Killefer | निदेशक | 5 नवमबर 2025 A | 27624 | 0 | 0 | $0 |
| Akhil Johri | निदेशक | 5 नवमबर 2025 A | 22868 | 0 | 0 | $0 |
| Sudhakar Ramakrishna | निदेशक | 5 नवमबर 2025 A | 2116 | 0 | 0 | $0 |
| Sheri H. Edison | निदेशक | 5 नवमबर 2025 A | 14848 | 0 | 0 | $0 |
| Christine Mundkur | निदेशक | 5 नवमबर 2025 A | 7536 | 0 | 0 | $0 |
| Gregory B Kenny | निदेशक | 5 नवमबर 2025 A | 64194 | 0 | 0 | $0 |
| Steven Barg | निदेशक | 15 नवमबर 2023 A | 4739 | 0 | 0 | $0 |
| Sujatha Chandrasekaran | निदेशक | 15 नवमबर 2023 A | 4739 | 0 | 0 | $0 |
| Bruce Downey | निदेशक | 9 नवमबर 2022 A | 53929 | 0 | 0 | $0 |
| COX CARRIE SMITH | निदेशक | 9 नवमबर 2022 A | 41631 | 0 | 0 | $0 |
| Dean A Scarborough | निदेशक | 18 अक्टूबर 2022 A | 11138 | 0 | 0 | $0 |
| John H Weiland | निदेशक | 11 नवमबर 2021 A | 11138 | 0 | 0 | $0 |
| Michael J Losh | निदेशक | 15 अक्टूबर 2021 A | 9988 | 0 | 0 | $0 |
| Calvin Darden | निदेशक | 9 नवमबर 2020 A | 39616 | 0 | 0 | $0 |
| Colleen F. Arnold | निदेशक | 12 नवमबर 2019 A | 35103 | 0 | 0 | $0 |
| David J Anderson | निदेशक | 16 जनवरी 2018 A | 9946 | 0 | 0 | $0 |
| David P King | निदेशक | 8 नवमबर 2017 A | 21044 | 0 | 0 | $0 |
| Clayton M Jones | निदेशक | 8 मई 2017 S | 0 | 0 | 0 | $0 |
| NOTEBAERT RICHARD C | निदेशक | 3 मार्च 2015 M | 35778 | 0 | 0 | $0 |
| John F Finn | निदेशक | 5 नवमबर 2014 A | 21074 | 0 | 0 | $0 |
| Glenn Britt | निदेशक | 7 मई 2014 A | 18314 | 0 | 0 | $0 |
| Jean G Spaulding | निदेशक | 6 नवमबर 2013 A | 17182 | 0 | 0 | $0 |
| David W Raisbeck | निदेशक | 2 नवमबर 2011 A | 17075 | 0 | 0 | $0 |
| James J Mongan MD | निदेशक | 3 नवमबर 2010 A | 7150 | 0 | 0 | $0 |
| Philip L Francis | निदेशक | 1 सितमबर 2009 D | 1021 | 0 | 0 | $0 |
| John B Mccoy | निदेशक | 5 नवमबर 2008 A | 2721 | 0 | 0 | $0 |
| Robert D Walter | निदेशक | 6 अक्टूबर 2008 M | 1531235 | 0 | 0 | $0 |
| Matthew D Walter | निदेशक | 7 जनवरी 2008 G | 2232 | 0 | 0 | $0 |
| Robert L Gerbig | निदेशक | 12 फ़रवरी 2007 M | 66218 | 0 | 0 | $0 |
| John F Havens | निदेशक | 8 नवमबर 2006 A | 30973 | 0 | 0 | $0 |
| David Bing | निदेशक | 3 अगस्त 2005 A | 3669 | 0 | 0 | $0 |
| Robert W Musslewhite | · | 5 नवमबर 2025 A | 2116 | 0 | 0 | $0 |
| David C Evans | · | 5 नवमबर 2025 A | 15373 | 0 | 0 | $0 |
| David L Schlotterbeck | · | 1 सितमबर 2009 D | 61523 | 0 | 0 | $0 |
| Michael D Ohalleran | · | 1 सितमबर 2009 D | 8458 | 0 | 0 | $0 |
| George N Conrades | · | 5 नवमबर 2008 A | 2653 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 148 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| PEZ · Invesco Exchange-Traded Fund Trust | 5.29% | 4961 SH | 2 अक्टूबर 2026 | दैनिक |
| FXG · First Trust Exchange-Traded AlphaDE… | 3.15% | 31414 NS | 31 जुलाई 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 2.97% | 12009 NS | 31 जुलाई 2026 | N-PORT |
| IYK · iShares Trust | 2.56% | 150019 SH | 11 सितमबर 2026 | दैनिक |
| NUMV · Nushares ETF Trust | 2.30% | 44435 NS | 31 जुलाई 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2.09% | 14948 SH | 2 अक्टूबर 2026 | दैनिक |
| SMRI · EA Series Trust | 1.84% | 51638 NS | 31 जुलाई 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.59% | 59923 SH | 2 अक्टूबर 2026 | दैनिक |
| NULV · Nushares ETF Trust | 1.53% | 145860 NS | 31 जुलाई 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1.51% | 597 NS | 31 जुलाई 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1.49% | 228600 NS | 31 जुलाई 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1.47% | 1193309 NS | 31 जुलाई 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 1.34% | 23570 SH | 19 अगस्त 2026 | दैनिक |
| UPSD · ETF Series Solutions | 1.31% | 6646 NS | 31 जुलाई 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1.25% | 527725 SH | 2 अक्टूबर 2026 | दैनिक |
| SRHQ · Elevation Series Trust | 1.20% | 11056 NS | 31 जुलाई 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 1.11% | 6347 SH | 2 अक्टूबर 2026 | दैनिक |
| RPV · Invesco Exchange-Traded Fund Trust | 1.10% | 79806 SH | 2 अक्टूबर 2026 | दैनिक |
| ESMV · iShares Trust | 1.06% | 350 SH | 11 सितमबर 2026 | दैनिक |
| PDP · Invesco Exchange-Traded Fund Trust | 1.06% | 67986 SH | 2 अक्टूबर 2026 | दैनिक |
| VOE · VANGUARD INDEX FUNDS | 0.96% | 1504470 SH | 19 अगस्त 2026 | दैनिक |
| ABFL · Abacus FCF ETF Trust | 0.92% | 21099 NS | 31 जुलाई 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 0.87% | 4124 NS | 31 जुलाई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.82% | 707389 SH | 19 अगस्त 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.78% | 111939 NS | 31 जुलाई 2026 | N-PORT |
| IWP · iShares Trust | 0.74% | 604324 SH | 11 सितमबर 2026 | दैनिक |
| LSEQ · Harbor ETF Trust | 0.70% | 468 NS | 31 जुलाई 2026 | N-PORT |
| IXJ · iShares Trust | 0.70% | 123272 SH | 11 सितमबर 2026 | दैनिक |
| CURE · Direxion Shares ETF Trust | 0.62% | 4609 NS | 31 जुलाई 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0.59% | 4662 NS | 31 जुलाई 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.55% | 31604 NS | 31 जुलाई 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.54% | 5075476 SH | 19 अगस्त 2026 | दैनिक |
| FTLS · First Trust Exchange-Traded Fund III | 0.51% | 54815 NS | 31 जुलाई 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.47% | 19654 SH | 2 अक्टूबर 2026 | दैनिक |
| LGDX · Tidal Trust III | 0.44% | 2735 NS | 31 जुलाई 2026 | N-PORT |
| EVUS · iShares Trust | 0.43% | 6970 SH | 11 सितमबर 2026 | दैनिक |
| RECS · Columbia ETF Trust I | 0.43% | 108869 NS | 31 जुलाई 2026 | N-PORT |
| IMCG · iShares Trust | 0.42% | 71722 SH | 11 सितमबर 2026 | दैनिक |
| QLC · FlexShares Trust | 0.42% | 18368 NS | 31 जुलाई 2026 | N-PORT |
| IWR · iShares Trust | 0.41% | 959539 SH | 11 सितमबर 2026 | दैनिक |
| LCOW · Pacer Funds Trust | 0.40% | 454 NS | 31 जुलाई 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.39% | 11919 NS | 31 जुलाई 2026 | N-PORT |
| IMCB · iShares Trust | 0.39% | 27470 SH | 11 सितमबर 2026 | दैनिक |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.36% | 7324 NS | 31 जुलाई 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0.36% | 5200 NS | 31 जुलाई 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.36% | 7082 NS | 31 जुलाई 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.35% | 445000 | 2 अक्टूबर 2026 | दैनिक |
| IMCV · iShares Trust | 0.35% | 16989 SH | 11 सितमबर 2026 | दैनिक |
| ACWV · iShares, Inc. | 0.33% | 46363 SH | 11 सितमबर 2026 | दैनिक |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.32% | 9479000 | 2 अक्टूबर 2026 | दैनिक |
| XOEF · iShares Trust | 0.31% | 293 SH | 11 सितमबर 2026 | दैनिक |
| IWS · iShares Trust | 0.29% | 189265 SH | 11 सितमबर 2026 | दैनिक |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.28% | 30714 NS | 31 जुलाई 2026 | N-PORT |
| GLOF · iShares Trust | 0.28% | 2389 SH | 11 सितमबर 2026 | दैनिक |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0.28% | 12847000 | 2 अक्टूबर 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.27% | 6869 NS | 31 जुलाई 2026 | N-PORT |
| ESGU · iShares Trust | 0.26% | 200383 SH | 11 सितमबर 2026 | दैनिक |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.26% | 17795 NS | 31 जुलाई 2026 | N-PORT |
| NULC · Nushares ETF Trust | 0.26% | 796 NS | 31 जुलाई 2026 | N-PORT |
| CATH · Global X Funds | 0.26% | 14490 NS | 31 जुलाई 2026 | N-PORT |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 0.25% | 7970000 | 2 अक्टूबर 2026 | दैनिक |
| DYNF · BlackRock ETF Trust | 0.25% | 443705 SH | 11 सितमबर 2026 | दैनिक |
| VFMO · VANGUARD WELLINGTON FUND | 0.25% | 21158 SH | 19 अगस्त 2026 | दैनिक |
| VIG · VANGUARD SPECIALIZED FUNDS | 0.24% | 1323136 SH | 19 अगस्त 2026 | दैनिक |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0.23% | 233192 SH | 2 अक्टूबर 2026 | दैनिक |
| VYM · VANGUARD WHITEHALL FUNDS | 0.23% | 934496 SH | 19 अगस्त 2026 | दैनिक |
| ESG · FlexShares Trust | 0.23% | 1320 NS | 31 जुलाई 2026 | N-PORT |
| SIZE · iShares Trust | 0.22% | 3988 SH | 11 सितमबर 2026 | दैनिक |
| LRGF · iShares Trust | 0.22% | 33556 SH | 11 सितमबर 2026 | दैनिक |
| VTV · VANGUARD INDEX FUNDS | 0.21% | 2225442 SH | 19 अगस्त 2026 | दैनिक |
| VFMF · VANGUARD WELLINGTON FUND | 0.21% | 6281 SH | 19 अगस्त 2026 | दैनिक |
| EUSA · iShares, Inc. | 0.20% | 16612 SH | 11 सितमबर 2026 | दैनिक |
| PFM · Invesco Exchange-Traded Fund Trust | 0.20% | 6670 SH | 2 अक्टूबर 2026 | दैनिक |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 813183 SH | 2 अक्टूबर 2026 | दैनिक |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.19% | 53931 SH | 19 अगस्त 2026 | दैनिक |
| IVE · iShares Trust | 0.19% | 388621 SH | 11 सितमबर 2026 | दैनिक |
| IUSV · iShares Trust | 0.18% | 205310 SH | 11 सितमबर 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.18% | 6098 SH | 2 अक्टूबर 2026 | दैनिक |
| IQSU · New York Life Investments ETF Trust | 0.17% | 2435 NS | 31 जुलाई 2026 | N-PORT |
| CHRI · Global X Funds | 0.16% | 57 NS | 31 जुलाई 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.16% | 4467000 | 2 अक्टूबर 2026 | दैनिक |
| DSI · iShares Trust | 0.16% | 35796 SH | 11 सितमबर 2026 | दैनिक |
| EGLE · Global X Funds | 0.13% | 12 NS | 31 जुलाई 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0.12% | 6 NS | 31 जुलाई 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0.12% | 12 NS | 31 जुलाई 2026 | N-PORT |
| DGRO · iShares Trust | 0.12% | 217268 SH | 11 सितमबर 2026 | दैनिक |
| VFVA · VANGUARD WELLINGTON FUND | 0.11% | 3797 SH | 19 अगस्त 2026 | दैनिक |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.10% | 7530 SH | 2 अक्टूबर 2026 | दैनिक |
| TOPC · iShares Trust | 0.10% | 144 SH | 11 सितमबर 2026 | दैनिक |
| ACVF · ETF Opportunities Trust | 0.10% | 675 NS | 31 जुलाई 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0.10% | 52911 SH | 19 अगस्त 2026 | दैनिक |
| DFSU · Dimensional ETF Trust | 0.10% | 9417 NS | 31 जुलाई 2026 | N-PORT |
| ILCG · iShares Trust | 0.10% | 12549 SH | 11 सितमबर 2026 | दैनिक |
| XVV · iShares Trust | 0.09% | 2689 SH | 11 सितमबर 2026 | दैनिक |
| USMV · iShares Trust | 0.09% | 91385 SH | 11 सितमबर 2026 | दैनिक |
| VOO · VANGUARD INDEX FUNDS | 0.09% | 6082026 SH | 19 अगस्त 2026 | दैनिक |
| VV · VANGUARD INDEX FUNDS | 0.09% | 273537 SH | 19 अगस्त 2026 | दैनिक |
| XRMI · Global X Funds | 0.09% | 194 NS | 31 जुलाई 2026 | N-PORT |
| XYLG · Global X Funds | 0.09% | 244 NS | 31 जुलाई 2026 | N-PORT |
| XYLD · Global X Funds | 0.09% | 12239 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.08% | 45685 NS | 31 जुलाई 2026 | N-PORT |
| IVV · iShares Trust | 0.08% | 2952119 SH | 11 सितमबर 2026 | दैनिक |
| PTLC · Pacer Funds Trust | 0.08% | 11916 NS | 31 जुलाई 2026 | N-PORT |
| XCLR · Global X Funds | 0.08% | 13 NS | 31 जुलाई 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.08% | 32252 NS | 31 जुलाई 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0.08% | 21 NS | 31 जुलाई 2026 | N-PORT |
| ILCB · iShares Trust | 0.08% | 4535 SH | 11 सितमबर 2026 | दैनिक |
| VOTE · TCW ETF Trust | 0.08% | 3959 NS | 31 जुलाई 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.08% | 1385 SH | 2 अक्टूबर 2026 | दैनिक |
| BKLC · BNY Mellon ETF Trust | 0.08% | 19424 NS | 31 जुलाई 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.08% | 40564 SH | 2 अक्टूबर 2026 | दैनिक |
| XTR · Global X Funds | 0.08% | 17 NS | 31 जुलाई 2026 | N-PORT |
| IWD · iShares Trust | 0.08% | 282063 SH | 11 सितमबर 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.08% | 7436156 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.08% | 38624 SH | 19 अगस्त 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.08% | 76610 SH | 19 अगस्त 2026 | दैनिक |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 169890 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.08% | 19715 SH | 19 अगस्त 2026 | दैनिक |
| TOV · EA Series Trust | 0.08% | 913 NS | 31 जुलाई 2026 | N-PORT |
| IWB · iShares Trust | 0.08% | 162672 SH | 11 सितमबर 2026 | दैनिक |
| IYY · iShares Trust | 0.08% | 10064 SH | 11 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.08% | 71472 NS | 31 जुलाई 2026 | N-PORT |
| USCL · iShares Trust | 0.08% | 9352 SH | 11 सितमबर 2026 | दैनिक |
| SPUU · Direxion Shares ETF Trust | 0.08% | 884 NS | 31 जुलाई 2026 | N-PORT |
| IWF · iShares Trust | 0.08% | 402774 SH | 11 सितमबर 2026 | दैनिक |
| QDPL · Pacer Funds Trust | 0.08% | 5627 NS | 31 जुलाई 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.08% | 32168 SH | 2 अक्टूबर 2026 | दैनिक |
| IWV · iShares Trust | 0.08% | 64328 SH | 11 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.08% | 304905 SH | 11 सितमबर 2026 | दैनिक |
| ILCV · iShares Trust | 0.07% | 4083 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.07% | 6802 NS | 31 जुलाई 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.07% | 183 SH | 2 अक्टूबर 2026 | दैनिक |
| DCOR · Dimensional ETF Trust | 0.07% | 9717 NS | 31 जुलाई 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0.07% | 1627 NS | 31 जुलाई 2026 | N-PORT |
| TOK · iShares Trust | 0.07% | 656 SH | 11 सितमबर 2026 | दैनिक |
| SPXL · Direxion Shares ETF Trust | 0.06% | 18311 NS | 31 जुलाई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.06% | 129668 NS | 31 जुलाई 2026 | N-PORT |
| URTH · iShares, Inc. | 0.06% | 20873 SH | 11 सितमबर 2026 | दैनिक |
| ACWI · iShares Trust | 0.05% | 74784 SH | 11 सितमबर 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.05% | 197885 SH | 19 अगस्त 2026 | दैनिक |
| DXUV · Dimensional ETF Trust | 0.01% | 343 NS | 31 जुलाई 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 40400 | 30 सितमबर 2026 | दैनिक |
| GTOS · Invesco Actively Managed Exchange-T… | 0.00% | 600 | 30 सितमबर 2026 | दैनिक |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
CAH विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
12-महीने का मूल्य लक्ष्य
15 विश्लेषक · 2026-10-02माध्य लक्ष्य $270.33 +18.4%
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।